Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
As the pharmaceutical landscape evolves, the complexity that these innovations require for their supply chains also increases. The development of…
Developing and commercialising gene therapies can be a costly process. Specialised manufacturing facilities are required, and custom medicines can only…
Research on antisense oligonucleotides (ASOs) began in the early 1980s, leading to rapid advances in RNA-based therapeutics over the past…
The COVID-19 pandemic revolutionized the role of diagnostic testing in healthcare. At-home and laboratory testing became comfortable—and accessible—for patients across…
It has been a long decade for the pharmaceutical industry. Some changes, like the pace of innovation and influx of…
The journey from groundbreaking pharmaceutical research to widespread deployment of novel drug treatments is riddled with challenges. The recent success…
According to GlobalData’s pharmaceutical intelligence centre, 25,078 clinical trials were underway in the period between January and November 2023. These…
Business decision makers have been buffeted by geopolitical and economic headwinds over the past year. But biomanufacturers are weathering the…
It isn’t often that pharmaceutical advancements break out of laboratories to become household names. Messenger RNA (mRNA) treatment, however, has…